NYSE: BMYBristol Myers Squibb Co Stock
BMY Price
$66.54
Fair Value Price
N/A
Market Cap
$149.98B
52 Week Low
$45.76
52 Week High
$68.34
P/E
-237.64x
P/B
2.99x
P/S
3.45x
PEG
N/A
Dividend Yield
2.65%
Revenue
$39.40B
Earnings
-$44.00M
Gross Margin
71.3%
Operating Margin
8.72%
Profit Margin
-0.1%
Debt to Equity
1.5
Operating Cash Flow
$12B
Beta
0.66
Next Earnings
Feb 4, 2021
Ex-Dividend
Dec 31, 2020
Next Dividend
Feb 1, 2021
Zen Score
High
Medium
Low
36
Industry average
Reasons for this score
BMY is good value based on its book value relative to its share price (2.99x), compared to the US market average (54.32x)
Valuation
BMY is good value based on its book value relative to its share price (2.99x), compared to the US Drug Manufacturers - General industry average (9.18x)
Valuation
BMY's Earnings (EBIT) of $3.44B can safely cover interest payments on company debt ($44.95B)
Financials
BMY News
Valuation
BMY price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-237.64x
Industry
-6.79x
Market
33.35x
BMY price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.99x
Industry
9.18x
Market
54.32x
BMY is good value based on its book value relative to its share price (2.99x), compared to the US market average (54.32x)
Valuation
BMY is good value based on its book value relative to its share price (2.99x), compared to the US Drug Manufacturers - General industry average (9.18x)
Valuation
BMY's financial health
Profit margin
Revenue
$10.5B
Net Income
$1.9B
Profit Margin
17.8%
BMY's Earnings (EBIT) of $3.44B can safely cover interest payments on company debt ($44.95B)
Financials
BMY's profit margin has decreased (-23.5%) in the last year from (23.4%) to (-0.1%)
Financials
Assets to liabilities
Assets
$125.5B
Liabilities
$75.3B
Debt to equity
0.9
BMY's short-term assets ($34.28B) exceed its short-term liabilities ($20.46B)
Financials
BMY's long-term liabilities ($54.84B) exceed its short-term assets ($34.28B)
Financials
BMY's debt has increased relative to shareholder equity (1.5), over the past 5 years ago (1.1)
Financials
BMY's debt to equity ratio (1.5) is considered high
Financials
Cash flow
Operating
$2.2B
Investing
-$165.0M
Financing
-$2.6B
BMY's operating cash flow ($12.42B) is sufficient to service the company's debt ($44.95B)
Financials
Bristol Myers Squibb Stock FAQ
©2021 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
